GlassScriptPhysician profile
Nicholas J Tarricone
NPI 1255371449
$25,603.51
in general payments reported to CMS, 2019-2025
6 companies · $29.83 in 2025
The $29.83 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $6,673 · 2021: $1,420 · 2022: $7,626 · 2023: $9,614 · 2024: $24.06 · 2025: $29.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,895 · Consulting Fee: $3,358 · Travel and Lodging: $718 · Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,895.00 |
| Consulting Fee | $3,357.50 |
| Travel and Lodging | $717.91 |
| Food and Beverage | $697.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $24,959.54 | 2020-2023 | Veozah |
| Myovant Sciences INC. | $244.42 | 2022 | |
| Abbvie INC. | $240.80 | 2019-2020 | |
| Aspira Women'S Health INC | $65.51 | 2022 | |
| Coopersurgical, INC. | $63.41 | 2022-2024 | Paragard T 380a, Mara Console |
| Karl Storz Endoscopy-America | $29.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Tarricone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.